We are live on ! Find out more
TCP

Tourbillon Capital Partners Portfolio holdings

AUM $6.26M
1-Year Est. Return 42.29%
This Fund
S&P 500
This Quarter Est. Return
+12.7%
1 Year Est. Return
-42.29%
3 Year Est. Return
-18.38%
5 Year Est. Return
+32.21%
10 Year Est. Return
–
AUM
$3.88B
AUM Growth
+$175M
Cap. Flow
-$49.8M
Cap. Flow %
-1.28%
Top 10 Hldgs %
43.83%
Holding
124
New
36
Increased
17
Reduced
19
Closed
51

Top Buys

Rank Stock Value
1
EXPE icon
Expedia Group
EXPE
+$237M
2
EPC icon
Edgewell Personal Care
EPC
+$154M
3
POST icon
Post Holdings
POST
+$89.9M
4
CRI icon
Carter's
CRI
+$86.4M
5
CMG icon
Chipotle Mexican Grill
CMG
+$71.7M

Top Sells

Rank Stock Value
1
AGN
Allergan Inc
AGN
+$95.7M
2
BHC icon
Bausch Health
BHC
+$85.2M
3
TSN icon
Tyson Foods
TSN
+$60.1M
4
AAPL icon
Apple
AAPL
+$55.2M
5
VYX icon
NCR Voyix
VYX
+$52.5M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 23.68%
2 Consumer Staples 9.95%
3 Healthcare 9.83%
4 Technology 7.83%
5 Communication Services 3.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STKL
51
DELISTED
SunOpta
STKL
$19.6M 0.51%
1,850,000
+595,000
+47% +$6.52M
DVAX
52
DELISTED
Dynavax Technologies
DVAX
$17.4M 0.45%
+775,000
New +$14.9M
NRG icon
53
NRG Energy
NRG
$25.4B
$16.4M 0.42%
+650,000
New +$16.4M
PTLA
54
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$15.2M 0.39%
+400,000
New +$13.7M
CENTA icon
55
Central Garden & Pet Co Class A
CENTA
$2.45B
$14.5M 0.37%
1,702,315
-685,185
-29% -$5.5M
RDUS
56
DELISTED
Radius Health, Inc.
RDUS
$13.4M 0.34%
+325,000
New +$14.6M
ACAD icon
57
Acadia Pharmaceuticals
ACAD
$4.95B
$13M 0.34%
+400,000
New +$13.7M
HZNP
58
CALL
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$13M 0.33%
+500,000
New +$9.17M
PPC icon
59
Pilgrim's Pride
PPC
$6.4B
$12.1M 0.31%
535,000
-115,000
-18% -$3.27M
MNKD icon
60
PUT
MannKind Corp
MNKD
$1.25B
$9.36M 0.24%
360,000
-300,000
-45% -$9.04M
SPB icon
61
CALL
Spectrum Brands
SPB
$2.03B
$8.96M 0.23%
100,000
-50,000
-33% -$4.67M
ARMK icon
62
Aramark
ARMK
$14.8B
$7.91M 0.2%
+346,250
New +$7.93M
QURE icon
63
uniQure
QURE
$3.09B
$7.3M 0.19%
+300,000
New +$6.54M
JASN
64
DELISTED
Jason Industries, Inc.
JASN
$6.75M 0.17%
953,170
-306,830
-24% -$2.44M
MW
65
DELISTED
THE MENS WAREHOUSE INC
MW
$6.53M 0.17%
+125,000
New +$6.06M
ELDN icon
66
Eledon Pharmaceuticals
ELDN
$266M
$5.84M 0.15%
3,191
– –
DYAX
67
DELISTED
DYAX CORPORATION
DYAX
$5.28M 0.14%
315,000
-35,000
-10% -$545K
ABUS icon
68
Arbutus Biopharma
ABUS
$881M
$4.8M 0.12%
+275,000
New +$5.63M
GNCA
69
DELISTED
Genocea Biosciences, Inc.
GNCA
$4.75M 0.12%
+50,050
New +$3.53M
DNOW icon
70
PUT
DNOW Inc
DNOW
$2.84B
$4.33M 0.11%
200,000
-1,324,800
-87% -$30.8M
ARAV
71
DELISTED
Aravive, Inc. Common Stock
ARAV
$3.67M 0.09%
+33,333
New +$3.91M
ADVM
72
CALL
DELISTED
Adverum Biotechnologies
ADVM
$3.45M 0.09%
+8,510
New +$3.6M
CHRS icon
73
Coherus Oncology
CHRS
$179M
$1.53M 0.04%
+50,000
New +$1.29M
AAPL icon
74
Apple
AAPL
$4.54T
– –
-2,000,000
Closed -$55.2M
AAPL icon
75
PUT
Apple
AAPL
$4.54T
– –
-1,200,000
Closed -$33.1M
1 2
3
4 5

Similar funds

BC
Blueport Capital Fort Worth, Texas $5.8M AUM 4.95% 1-Year Est. Return
LBG
Lloyds Banking Group London, United Kingdom $7.15M AUM 0.75% 1-Year Est. Return
TGA
Trilogy Global Advisors Winter Park, Florida $712K AUM 8.54% 1-Year Est. Return
ACM
Archer Capital Management New York $16.2M AUM 17.01% 1-Year Est. Return
MGFS
Miller Green Financial Services Spring, Texas $17.6M AUM
LA
Lexington Advisors New York $18.7M AUM 48.36% 1-Year Est. Return
CT
CMT Trading Chicago, Illinois $22.4M AUM 78.15% 1-Year Est. Return
NMM
NGP MR Management Dallas, Texas $23.4M AUM 15.8% 1-Year Est. Return

Tourbillon Capital Partners's Q1 2015 Portfolio in Review

As of Q1 2015, Tourbillon Capital Partners held 124 positions worth $3.88B, up 4.7% from $3.71B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Tourbillon Capital Partners's Q1 2015 filing shows 36 new, 17 increased, 19 reduced and 51 closed positions. Its largest new stake was Edgewell Personal Care: 1,551,350 shares worth $159M. The largest sale was Allergan Inc, an estimated $95.7M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 24% of assets, up from 9.6% a quarter earlier, followed by Consumer Staples and Healthcare.

  • Tourbillon Capital Partners's largest Q1 2015 buy was Edgewell Personal Care: 1,551,350 shares worth $159M.
  • Tourbillon Capital Partners added most to Expedia Group in Q1 2015, an estimated $237M increase.
  • Tourbillon Capital Partners's biggest Q1 2015 reduction was Bausch Health, cutting an estimated $85.2M.
  • Tourbillon Capital Partners fully exited Allergan Inc in Q1 2015, selling an estimated $95.7M.
  • Tourbillon Capital Partners's ten largest holdings make up 44% of its $3.88B portfolio in Q1 2015.
  • Tourbillon Capital Partners opened 36 new positions and closed 51 in Q1 2015.
  • Tourbillon Capital Partners's portfolio value rose 4.7% quarter-over-quarter to $3.88B.

Based on Tourbillon Capital Partners's 13F filing for Q1 2015, filed 15 May 2015.